Tibet Aim Pharm Inc Asset Resilience Ratio

Latest as of March 2026: 18.13%

Tibet Aim Pharm Inc asset resilience ratio. Tibet Aim Pharm Inc (002826) has an Asset Resilience Ratio of 18.13% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Tibet Aim Pharm Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥200.00 Million

≈ $29.27 Million USD Cash + Short-term Investments

Total Assets

CN¥1.10 Billion

≈ $161.45 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio of Tibet Aim Pharm Inc (2014–2023)

Asset resilience ratio of Tibet Aim Pharm Inc from 2014 to 2023. This chart shows how Tibet Aim Pharm Inc's Asset Resilience Ratio has changed over time. Read Tibet Aim Pharm Inc (002826) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Tibet Aim Pharm Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Tibet Aim Pharm Inc.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥200.00 Million	18.13%
Total Liquid Assets	CN¥200.00 Million	18.13%

Asset Resilience Insights

Good Liquidity Position: Tibet Aim Pharm Inc maintains a healthy 18.13% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Tibet Aim Pharm Inc Industry Peers by Asset Resilience Ratio

Compare Tibet Aim Pharm Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

Tibet Aim Pharm Inc Asset Resilience Ratio by Year (2014–2023)

Tibet Aim Pharm Inc asset resilience ratio by year from 2014 to 2023. The table below shows the annual Asset Resilience Ratio data for Tibet Aim Pharm Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	0.00%	CN¥-2.00 ≈ $-0.29	CN¥927.74 Million ≈ $135.76 Million	-3.59pp
2019-12-31	3.59%	CN¥30.00 Million ≈ $4.39 Million	CN¥835.41 Million ≈ $122.25 Million	+3.73pp
2015-12-31	-0.14%	CN¥-570.74K ≈ $-83.52K	CN¥397.70 Million ≈ $58.20 Million	-0.96pp
2014-12-31	0.82%	CN¥2.20 Million ≈ $321.93K	CN¥268.42 Million ≈ $39.28 Million	--

pp = percentage points

About Tibet Aim Pharm Inc

SHE:002826 China Drug Manufacturers - Specialty & Generic

Market Cap

$415.74 Million

CN¥2.84 Billion CNY

Market Cap Rank

#12910 Global

#3770 in China

Share Price

CN¥14.90

Change (1 day)

+2.69%

52-Week Range

CN¥14.51 - CN¥22.24

All Time High

CN¥32.76